Article
Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease.
The Journal of allergy and clinical immunology - 1 Jun 2009
Rodríguez Elke, Baurecht Hansjörg, Herberich Esther, Wagenpfeil Stefan, Brown Sara J, Cordell Heather J, Irvine Alan D, Weidinger Stephan
Abstract excerpt
BACKGROUND: The discovery of filaggrin (FLG) null mutations as a major risk factor for eczema represents a milestone toward the understanding of an important mechanism in this complex disease. However, published studies demonstrate differences concerning design and effect size, and conflicting results for asthma have been reported. OBJECTIVES: We sought to provide a more accurate estimate of FLG effect sizes and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
